- 1. (-)-Cyclophosphamide
- [precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent; used in the treatment of lymphomas, leukemias and other cancers, and as an immunosupressive agent to prevent transplant rejection; its side effect, alopecia, has been used for defleecing sheep; may also cause sterility, birth defects, mutations, and cancer. ( CSP )] (UMLS (NCI) C0010583) =Organophosphorus Compound; Pharmacologic Substance =[AN000] ANTINEOPLASTICS;
phosphamide;
[IM600] IMMUNE SUPPRESSANTS;
Phosphoramide Mustards;
Antineoplastic Alkylating Agent;
=2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin- 2-amine;
CYCLOPHOSPHAMIDE 100 MG;
CYCLOPHOSPHAMIDE 200 MG;
CYCLOPHOSPHAMIDE 500 MG;
CYCLOPHOSPHAMIDE 25 MG;
CYCLOPHOSPHAMIDE 50 MG;
CYCLOPHOSPHAMIDE 2 GM;
CYCLOPHOSPHAMIDE 1 GM;
CYCLOPHOSPHAMIDE 1 GM/VIL;
CYCLOPHOSPHAMIDE 2 GM/VIL | - 51. cyclohexadiene
- [ ] (UMLS (CSP) C0526078) =Organic Chemical
|
- 2. 1-(4-(2-Cyclopropylmethoxy)ethyl)phenoxy)-3-))1-methylethyl)amino)-2-propanol
- [A racemic mixture and selective beta-1 adrenergic receptor antagonist with antihypertensive and anti-glaucoma activities and devoid of intrinsic sympathomimetic activity. Betaxolol selectively and competitively binds to and blocks beta-1 adrenergic receptors in the heart, thereby decreasing cardiac contractility and rate. This leads to a reduction in cardiac output and lowers blood pressure. When applied topically in the eye, this agent reduces aqueous humor secretion and lowers the intraocular pressure (IOP). In addition, betaxolol prevents the release of renin, a hormone secreted by the kidneys that causes constriction of blood vessels. ( NCI )] (UMLS (NCI) C0005320) =Organic Chemical; Pharmacologic Substance ;
| - 52. cyclohexadienone
- [ ] (UMLS (CSP) C0598257) =Organic Chemical
|
- 3. 1-cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol Hydrochloride
- [The hydrochloride salt form of procyclidine, with anticholinergic properties. Procyclidine hydrochloride competitively binds to striatal cholinergic receptors, thereby diminishing acetylcholine activity and ultimately reducing the frequency and severity of akinesia, rigidity, and tremor associated with uncontrollable body movements. In addition, this agent may block the re-uptake of dopamine by nerve terminals, thereby increasing dopamine activity. ( NCI )] (UMLS (NCI) C0546874) =Organic Chemical; Pharmacologic Substance =Procyclidine;
=PROCYCLIDINE HYDROCHLORIDE 5 MG;
| - 53. cyclohexane
- [group of alicyclic hydrocarbons with the general formula R-C6H11. ( CSP )] (UMLS (CSP) C0010568) =Organic Chemical ;
=Cycloparaffins;
cyclic compound =1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol;
Cyclohexanecarboxylic Acids;
Cyclohexanols;
KETAMINE;
A 4166;
|
- 4. 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid
- [An anti-infection drug that is also being studied in bladder cancer chemotherapy. ( NCI )] (UMLS (NCI) C0008809) =Organic Chemical; Pharmacologic Substance =Quinolones;
antibacterial agent;
[AM900] ANTI-INFECTIVES, OTHER;
[OP201] ANTIBACTERIALS, TOPICAL OPHTHALMIC =1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, Monohydrochloride, Monohydrate;
CIPROFLOXACIN 10 MG/ML;
CIPROFLOXACIN 2 MG/ML;
24 HR Ciprofloxacin 500 MG Extended Release Tablet;
24 HR Ciprofloxacin 1000 MG Extended Release Tablet | - 54. cyclohexane carboxylate
- [ ] (UMLS (CSP) C0920449) =Organic Chemical
|
- 5. 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, Monohydrochloride, Monohydrate
- [The hydrochloride salt form of ciprofloxacin, a fluoroquinolone related to nalidixic acid with antibacterial activity. Ciprofloxacin hydrochloride exerts its bactericidal effect by interfering with the bacterial DNA gyrase, thereby inhibiting the DNA synthesis and preventing bacterial cell growth. ( NCI )] (UMLS (NCI) C0282104) =Organic Chemical; Antibiotic ;
=1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid;
=CIPROFLOXACIN HYDROCHLORIDE 250 MG/5ML;
CIPROFLOXACIN HYDROCHLORIDE 500 MG/5ML;
CIPROFLOXACIN HYDROCHLORIDE 02 %;
CIPROFLOXACIN HYDROCHLORIDE 250 MG;
CIPROFLOXACIN HYDROCHLORIDE 500 MG;
CIPROFLOXACIN HYDROCHLORIDE 750 MG;
CIPROFLOXACIN HYDROCHLORIDE 100 MG;
CIPROFLOXACIN HYDROCHLORIDE 0.3 %;
| - 55. cyclohexane/cyclohexene carboxylate
- [ ] (UMLS (CSP) C0178580) =Organic Chemical =cyclic acid;
=shikimate;
|
- 6. 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
- [A synthetic 8-methoxyfluoroquinolone with antibacterial activity against a wide range of gram-negative and gram-positive microorganisms. Gatifloxacin exerts its effect through inhibition of DNA gyrase, an enzyme involved in DNA replication, transcription and repair, and inhibition of topoisomerase IV, an enzyme involved in partitioning of chromosomal DNA during bacterial cell division. ( NCI )] (UMLS (NCI) C0753645) Gatifloxacin;
GATIFLOXACIN PREPARATION =Organic Chemical; Antibiotic ;
=[AM900] ANTI-INFECTIVES, OTHER;
Unclassified Ingredients =GATIFLOXACIN 10 MG/ML;
GATIFLOXACIN 200 MG;
GATIFLOXACIN 400 MG;
GATIFLOXACIN 2 MG/ML;
GATIFLOXACIN 0.3 %;
| - 56. Cyclohexanecarboxylic Acid, 4-(aminomethyl)-, trans-
- [A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action. ( NCI )] (UMLS (NCI) C0040613) =Organic Chemical; Pharmacologic Substance ;
=Cyclohexanecarboxylic Acids;
[BL300] ANTIHEMORRHAGICS =TRANEXAMIC ACID PWDR;
TRANEXAMIC ACID 100 MG/ML;
TRANEXAMIC ACID 500 MG |
- 7. 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium
- [A methyl derivative of noroxymorphone with selective, opioid-receptor antagonistic activity. Methylnaltrexone displaces opioids from peripheral opioid receptors in the gastrointestinal tract, the bladder, and the skin, resulting in decreases in opioid-related constipation, urinary retention, and pruritis, respectively. Methylnaltrexone does not cross the blood-brain barrier and does not affect the centrally-mediated analgesic effect of opioids. ( NCI )] (UMLS (NCI) C0066411) =Organic Chemical; Pharmacologic Substance ;
| - 57. cyclohexanone
- [cyclohexane ring substituted by one or more ketones in any position. ( CSP )] (UMLS (CSP) C0056760) =Organic Chemical ;
=cyclic ketone;
=KETAMINE |
- 8. 2'3' cyclic nucleotide phosphodiesterase
- [Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-. ( MSH )] (UMLS (CSP) C0000184) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 58. cyclohexene carboxylate
- [ ] (UMLS (CSP) C0920450) =Organic Chemical
|
- 9. 3'5' cyclic nucleotide phosphodiesterase
- [Enzymes that catalyze the hydrolysis of CYCLIC AMP to form adenosine 5'-phosphate. The enzymes are widely distributed in animal tissue and control the level of intracellular cyclic AMP. Many specific enzymes classified under this heading demonstrate additional spcificity for 3',5'-cyclic IMP and CYCLIC GMP. ( MSH )] (UMLS (CSP) C0000359) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 59. cycloheximide
- [antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus; it inhibits protein synthesis in eukaryotic cells by blocking translation of messenger RNA on the ribosome. ( CSP )] (UMLS (CSP) C0010572) =Organic Chemical; Antibiotic =antifungal antibiotic;
piperidine |
- 10. 3'5'-cyclic ester of AMP
- [adenine nucleotide containing one phosphate group which is esterified to both the 3' and 5' positions of the sugar moiety; it is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones. ( CSP )] (UMLS (NCI) C0001455) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 60. cyclohexylamine
- [ ] (UMLS (CSP) C0010573) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
|
- 11. 3,5 cyclic AMP synthetase
- [An enzyme of the lyase class that catalyzes the formation of CYCLIC AMP and pyrophosphate from ATP. EC 4.6.1.1. ( MSH )] (UMLS (CSP) C0001492) =Amino Acid, Peptide, or Protein; Enzyme
| - 61. Cyclomen
- (UMLS (NCI) C0813502) Danocrine;
Danol;
Ladogal =Steroid; Pharmacologic Substance ;
|
- 12. 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
- [A quinolinone derivative and cellular phosphodiesterase inhibitor, more specific for phosphodiesterase III (PDE III). Although the exact mechanism of action of is unknown, cilostazol and its metabolites appears to inhibit PDE III activity, thereby suppressing cyclic adenosine monophosphate (cAMP) degradation. This results in an increase in cAMP in platelets and blood vessels, leading to inhibition of platelet aggregation and vasodilation. ( NCI )] (UMLS (NCI) C0055729) =Organic Chemical; Pharmacologic Substance ;
=Tetrazoles;
[CV900] CARDIOVASCULAR AGENTS, OTHER =CILOSTAZOL 100 MG;
CILOSTAZOL 50 MG;
| - 62. cyclooxygenase inhibitor
- [compounds or agents that combine with cyclooxygenase (prostaglandin endoperoxide synthase) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. ( CSP )] (UMLS (CSP) C0085387) =Pharmacologic Substance =NSAIDs;
enzyme inhibitor;
oxidoreductase inhibitor;
=COX2 inhibitor;
1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid |
- 13. Cycad
- [A plant class of Cycadophyta. ( MSH )] (UMLS (CSP) C0598230) =Plant ;
| - 63. cyclopentane
- [C5H10, colorless liquid, used as a solvent. ( CSP )] (UMLS (CSP) C0010580) =Organic Chemical ;
=Cycloparaffins;
cyclic compound =caramiphen;
carbetapentane |
- 14. cycasin
- [Carcinogenic and neurotoxic glycoside occurring in a number of plant species, including Cycas revoluta. ( MSH )] (UMLS (CSP) C0010522) =Organic Chemical; Biologically Active Substance; Hazardous or Poisonous Substance
| - 64. CYCLOPENTOLATE
- [A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia. ( MSH )] (UMLS (NCI) C0010582) =Organic Chemical; Pharmacologic Substance =phenylacetate;
[OP600] MYDRIATICS/CYCLOPLEGICS, TOPICAL OPHTHALMIC =CYCLOPENTOLATE HYDROCHLORIDE;
|
- 15. cyclazocine
- [analgesic with mixed narcotic agonist-antagonist properties. ( CSP )] (UMLS (CSP) C0010526) =Organic Chemical; Pharmacologic Substance ;
=[CN100] ANALGESICS;
Narcotic Antagonist;
6,7 benzomorphan;
| - 65. cyclophilin
- [catalyses one step in the refolding of urea denatured ribonuclease A enzyme is identical to the protein which binds the immunosuppressive drug cyclosporin. ( CSP )] (UMLS (CSP) C0136073) =Amino Acid, Peptide, or Protein; Enzyme ;
=isomerase;
|
- 16. cyclic acid
- [carboxylic acids that have a homocyclic ring structure in which all the ring atoms are carbon. ( CSP )] (UMLS (CSP) C0596396) =Organic Chemical ;
=carboxylate;
=cyclohexane/cyclohexene carboxylate;
phenylcarboxylate | - 66. CYCLOPHORIA
- [ ] (UMLS (ICD9CM) C0152219) =Sign or Symptom ;
|
- 17. Cyclic Agranulocytosis
- (UMLS (NCI) C0221023) =Disease or Syndrome ;
| - 67. Cyclophosphamide/Cyclosporine/Fludarabine/Methylprednisolone/Thiotepa
- (UMLS (NCI) C1328015) =Therapeutic or Preventive Procedure ;
|
- 18. cyclic alcohol
- [any alcohol containing a ring structure. ( CSP )] (UMLS (CSP) C0596397) =Organic Chemical ;
=alcohol;
=phenol;
| - 68. Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Pegaspargase/Thioguanine/Vincristine
- (UMLS (NCI) C1327984) =Therapeutic or Preventive Procedure ;
|
- 19. cyclic amine
- [any amine containing a ring structure. ( CSP )] (UMLS (CSP) C0596398) =Organic Chemical ;
=amine;
=aminobenzene;
naphthylamine;
phenylalkylamine;
| - 69. Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Filgrastim/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine
- (UMLS (NCI) C1134673) =Therapeutic or Preventive Procedure
|
- 20. cyclic AMP receptor
- [cell surface receptor found in slime mold Dictyostelium discoideum, where cyclic AMP functions both intra- and extra-cellularly; or, the CRP of E. coli and other systems, a cystolic, DNA-binding protein of the steroid receptor type. ( CSP )] (UMLS (CSP) C0034796) =Amino Acid, Peptide, or Protein; Receptor ;
=Purinergic Receptor;
| - 70. Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Thioguanine/Vincristine
- (UMLS (NCI) C1134445) =Therapeutic or Preventive Procedure ;
|
- 21. cyclic compound
- [chemical compounds that contain a ring of atoms. ( CSP )] (UMLS (CSP) C0596399) =Organic Chemical ;
=Organic Chemical;
=bicyclic compound;
Bridged Compounds;
cyclohexane;
cyclopentane;
cyclopropane;
Heterocyclic Compound;
carbopolycyclic compound;
cycloheptane;
cycloalkene;
spirane | - 71. Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide Phosphate/Methotrexate
- (UMLS (NCI) C1328103) =Therapeutic or Preventive Procedure; ;
|
- 22. Cyclic Entry/Exit Indicator
- (UMLS (HL7) C1547880) =Idea or Concept =HL7 Vocabulary Version 2.5;
=The last service request in a cyclic group.;
The first service request in a cyclic group;
| - 72. Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate
- (UMLS (NCI) C0935860) =Therapeutic or Preventive Procedure
|
- 23. cyclic ketone
- [any ketone containing a ring structure. ( CSP )] (UMLS (CSP) C0576783) =Organic Chemical =KETONE;
=LACTONE;
pyrone;
Benzoquinone Compound;
cyclohexanone;
phenone;
semiquinone;
| - 73. Cyclophosphamide/Cytarabine/Dexamethasone/Mitoxantrone
- (UMLS (NCI) C0879546) =Therapeutic or Preventive Procedure ;
|
- 24. cyclic nucleoside monophosphate
- [cyclic nucleoside containing a single phosphate radical. ( CSP )] (UMLS (CSP) C0178577) =Nucleic Acid, Nucleoside, or Nucleotide =nucleoside monophosphate;
=3'5'-cyclic ester of AMP;
cGMP | - 74. Cyclophosphamide/Cytarabine/Fludarabine
- (UMLS (NCI) C0879376) =Therapeutic or Preventive Procedure
|
- 25. cyclic peptide
- [any peptide containing a ring structure. ( CSP )] (UMLS (CSP) C0030957) =Amino Acid, Peptide, or Protein =Peptides;
=actinomycin;
Ciclosporin;
bacitracin;
Capreomycin Sulfate;
Cyclosporins;
2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3;
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane Cyclic Peptide Deriv;
POLYMYXIN;
Mikamycin | - 75. Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0879561) =Therapeutic or Preventive Procedure
|
- 26. Cyclic(L-alanyl-D-alanyl-eta-oxo-L-alpha-aminooxiraneoctanoyl-D-prolyl)
- [A host-specific toxin from the maize pathogen Cochliobolus carbonum. An inhibitor of histone deacetylase, it is a cyclic tetrapeptide containing an epoxide alpha-amino acid. Inhibition of histone deacetylase is sensitive to mercaptoethanol treatment. ( NCI )] (UMLS (NCI) C0062143) =Amino Acid, Peptide, or Protein
| - 76. Cyclophosphamide/cytarabine/mercaptopurine/methotrexate/prednisolone
- (UMLS (NCI) C0935859) =Therapeutic or Preventive Procedure
|
- 27. Cyclical
- (UMLS (HL7) C1548956) =Idea or Concept =Sequence/Results Flag;
| - 77. Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Prednisone
- (UMLS (NCI) C0879409) =Therapeutic or Preventive Procedure
|
- 28. cyclin
- [family of proteins which accumulate during interphase of the eukaryotic cell cycle and are destroyed at the conclusion of mitosis; believed to be involved in inducing mitosis. ( CSP )] (UMLS (CSP) C0079183) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Cell Cycle Protein;
| - 78. Cyclophosphamide/Cytarabine/Topotecan
- (UMLS (NCI) C0879588) =Therapeutic or Preventive Procedure
|
- 29. Cyclin
- [cofactor of DNA polymerase delta; required for DNA replication and cell cycle progression; used as a biomarker for a variety of disorders, including neoplasms and systemic lupus erythematosus. ( CSP )] (UMLS (NCI) C0072108) =Amino Acid, Peptide, or Protein; Biologically Active Substance =nuclear protein;
Cell Cycle Protein | - 79. Cyclophosphamide/Dactinomycin/Irinotecan/Vincristine
- (UMLS (NCI) C1328054) =Therapeutic or Preventive Procedure ;
|
- 30. Cyclin Gene
- [These genes encode member proteins of the highly conserved cyclin family. They are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. (From RefSeq Summary and NCI) ( NCI )] (UMLS (NCI) C1333183) =Gene or Genome ;
| - 80. Cyclophosphamide/Daunorubicin/Dexamethasone/Imatinib Mesylate/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C1134459) =Therapeutic or Preventive Procedure ;
|
- 31. Cyclin-Dependent Kinase Gene
- [Cyclin-Dependent Kinase Genes encode Cyclin-Dependent Kinases, eukaryotic phosphoregulated protein kinases that physically associate with cyclins to achieve full enzymatic activity and control cell cycle progression. (NCI) ( NCI )] (UMLS (NCI) C1333181) =Gene or Genome ;
| - 81. Cyclophosphamide/Decitabine/Doxorubicin
- (UMLS (NCI) C1328118) =Therapeutic or Preventive Procedure; ;
|
- 32. Cyclitis
- [Inflammation of the ciliary body. ( NCI )] (UMLS (NCI) C0010543) =Disease or Syndrome
| - 82. Cyclophosphamide/Detox-B Adjuvant/Interleukin-2
- (UMLS (NCI) C0935655) =Therapeutic or Preventive Procedure
|
- 33. cyclization
- [chemical reaction that causes parts of a molecule to join so that a ring of atoms is formed within the molecule. ( CSP )] (UMLS (CSP) C0010546) =Natural Phenomenon or Process =chemical reaction;
=Diels Alder reaction;
| - 83. Cyclophosphamide/Dexamethasone/Doxorubicin
- (UMLS (NCI) C1134563) =Therapeutic or Preventive Procedure ;
|
- 34. CYCLIZINE
- [A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935) ( MSH )] (UMLS (NCI) C0010547) =Organic Chemical; Pharmacologic Substance ;
=Piperazines;
[CN550] ANTIVERTIGO AGENTS =Cyclizine Lactate;
CYCLIZINE HYDROCHLORIDE;
Cyclizine Lactate;
CYCLIZINE HYDROCHLORIDE | - 84. Cyclophosphamide/Dexamethasone/Doxorubicin/Leucovorin Calcium/Methotrexate/Vincristine
- (UMLS (NCI) C1134642) =Therapeutic or Preventive Procedure
|
- 35. Cyclizine Lactate
- (UMLS (NCI) C0304305) =Organic Chemical; Pharmacologic Substance ;
=CYCLIZINE;
=CYCLIZINE LACTATE 50 MG/ML | - 85. Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vinblastine
- (UMLS (NCI) C0935717) =Therapeutic or Preventive Procedure
|
- 36. Cyclo((S)-gamma-oxo-L-alpha-aminooxiraneoctanoyl-L-phenylalanyl-L-phenylalanyl-D-2-piperidinecarbonyl)
- [An epoxide-containing cyclotetrapeptide with antitumor activity. It is an irreversible inhibitor of histone deacetylase. ( NCI )] (UMLS (NCI) C0084839) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 86. Cyclophosphamide/Dexamethasone/Doxorubicin/Rituximab/Vincristine
- (UMLS (NCI) C1134697) =Therapeutic or Preventive Procedure ;
|
- 37. Cyclo-Prostin
- [The sodium salt form of epoprostenol, a synthetic prostacyclin, a member of the family of prostaglandins, with vasodilatory and anticoagulant activity. Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. This agent also inhibits platelet aggregation by antagonizing platelet glycoprotein (GP) IIb/IIIa receptors, thereby preventing thrombus formation. ( NCI )] (UMLS (NCI) C0354594) =Eicosanoid; Pharmacologic Substance =EPOPROSTENOL;
=EPOPROSTENOL SODIUM 1.5 MG;
EPOPROSTENOL SODIUM 0.5 MG;
| - 87. Cyclophosphamide/Dexamethasone/Etoposide/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine
- (UMLS (NCI) C1134461) =Therapeutic or Preventive Procedure
|
- 38. cycloaddition
- [ ] (UMLS (CSP) C0598128) =Phenomenon or Process
| - 88. Cyclophosphamide/Dexamethasone/Mitoxantrone
- (UMLS (NCI) C0879544) =Therapeutic or Preventive Procedure ;
|
- 39. cycloalkene
- [cyclic unsaturated hydrocarbon having at least one carbon-carbon double bond in the ring. ( CSP )] (UMLS (CSP) C0576732) =Organic Chemical =cyclic compound;
=benzene;
biphenyl compound;
toluene | - 89. Cyclophosphamide/Dexrazoxane/Doxorubicin
- (UMLS (NCI) C0935845) =Therapeutic or Preventive Procedure
|
- 40. CYCLOBENZAPRINE
- [A centrally acting skeletal muscle relaxant with antidepressant activity. The exact mechanism of action of cyclobenzaprine has not been fully determined, but this drug seems to primarily act at the brain stem to reduce tonic somatic motor activity, influencing both gamma and alpha motor neurons leading to a reduction in muscle spasms. ( NCI )] (UMLS (NCI) C0056732) =Organic Chemical; Pharmacologic Substance ;
=amitriptyline;
[MS200] SKELETAL MUSCLE RELAXANTS =10,11delta-Amitriptyline Hydrochloride | - 90. Cyclophosphamide/Dexrazoxane/Doxorubicin/Oblimersen
- (UMLS (NCI) C1134674) =Therapeutic or Preventive Procedure
|
- 41. Cyclobutane Pyrimidine Dimer
- [covalently linked adjacent pyrimidine bases (usually thymidine) on a strand of DNA produced by UV light or other radiation; the mutation blocks both transcription and replication until excised and repaired. ( CSP )] (UMLS (NCI) C0034286) =Nucleic Acid, Nucleoside, or Nucleotide ;
=DNA damage;
| - 91. Cyclophosphamide/Docetaxel
- (UMLS (NCI) C0935668) Docetaxel/Cyclophosphamide;
=Therapeutic or Preventive Procedure |
- 42. Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)-, Hydrochloride
- [The hydrochloride salt form of sibutramine, a phenethylamine derivative with appetite depressant property. Sibutramine hydrochloride metabolites M1 and M2 competitively inhibit the reuptake of norepinephrine, serotonin, and to a lesser degree dopamine by pre-synaptic nerve terminals, thereby promoting a sense of satiety, leading to a decrease in calorie intake, and possibly an increase in resting metabolic rate. This agent does not exhibit anticholinergic or antihistaminic effects. ( NCI )] (UMLS (NCI) C0142278) =Organic Chemical; Pharmacologic Substance =sibutramine;
=SIBUTRAMINE HYDROCHLORIDE 15 MG;
SIBUTRAMINE HYDROCHLORIDE 10 MG;
SIBUTRAMINE HYDROCHLORIDE 5 MG | - 92. Cyclophosphamide/Doxorubicin/Epratuzumab/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C1327943) =Therapeutic or Preventive Procedure; ;
|
- 43. CYCLOCRYOTHERAPY
- [ ] (UMLS (ICD9CM) C0197666) =Therapeutic or Preventive Procedure
| - 93. Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C1327899) =Therapeutic or Preventive Procedure ;
|
- 44. cyclodextrin
- [compound containing six or more D-glucose units joined through 1,4-alpha linkages to form a ring; used as complexing agents and in enzymology. ( CSP )] (UMLS (CSP) C0010558) =Carbohydrate; Biologically Active Substance ;
=glucan;
| - 94. Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Vincristine
- (UMLS (NCI) C0879288) =Therapeutic or Preventive Procedure
|
- 45. cyclodialysis
- [ ] (UMLS (CSP) C0197526) =Therapeutic or Preventive Procedure
| - 95. Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C0879421) =Therapeutic or Preventive Procedure
|
- 46. CYCLODIATHERMY
- [ ] (UMLS (ICD9CM) C1261306) =Therapeutic or Preventive Procedure
| - 96. Cyclophosphamide/Doxorubicin/Etoposide/Rituximab/Vincristine
- (UMLS (NCI) C0935756) =Therapeutic or Preventive Procedure
|
- 47. Cyclodisone
- [A cyclic sulfonate ester with potential antineoplastic activity. As an alkylating agent, clyclodisone induces the formation of DNA interstrand crosslinks, DNA strand breaks, and alkali-labile lesions in the DNA of some tumor cell lines. Alkylating agents exert cytotoxic and chemotherapeutic effects by transferring alkyl groups to DNA, thereby damaging DNA and interfering with DNA synthesis and cell division. (NCI04) ( NCI )] (UMLS (NCI) C0056746) =Organic Chemical; Pharmacologic Substance ;
| - 97. Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Rituximab/Vincristine
- (UMLS (NCI) C1134550) =Therapeutic or Preventive Procedure ;
|
- 48. Cyclododecadepespipeptide Neutral Ionophore
- [A cyclic depsipeptide isolated from the bacterium Streptomyces fulvissimus. As a potassium-specific ionophore, mould element causes loss of mitochondrial membrane potential, thereby initiating cellular apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C0042287) =Amino Acid, Peptide, or Protein; Antibiotic ;
| - 98. Cyclophosphamide/Doxorubicin/Iodine I 131 Tositumomab/Prednisone/Vincristine
- (UMLS (NCI) C0935736) =Therapeutic or Preventive Procedure
|
- 49. Cyclodol
- (UMLS (NCI) C0701016) =Organic Chemical; Pharmacologic Substance ;
| - 99. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Rituximab/Vincristine
- (UMLS (NCI) C1327931) =Therapeutic or Preventive Procedure; ;
|
- 50. cycloheptane
- [ ] (UMLS (CSP) C0178579) =Organic Chemical =cyclic compound;
=amitriptyline;
(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide;
cyproheptadine;
NORTRIPTYLINE;
DIZOCILPINE;
| - 100. Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Vincristine
- (UMLS (NCI) C1327930) =Therapeutic or Preventive Procedure; ;
|
home
